Ophthalmic Eye Drops PCD Franchise – The growing number of eye conditions like cataracts, glaucoma, dry eye syndrome, and allergies is driving up the need for ophthalmic eye drops. The increasing global population age and rising occurrence of eye-related conditions are fueling the need for ophthalmic eye drops.
The anticipated increase in awareness of eye health and regular eye check-ups is projected to drive the demand for ophthalmic eye drops, resulting in prompt identification and management of eye issues.
Due to the growing demand, many new entrepreneurs and pharmaceutical professionals are achieving extra benefits and significant profits by choosing to participate in the Ophthalmic Eye Drops PCD Franchise.
Various factors such as the rising number of eye diseases, the increasing elderly population, the need for new medications, and the lack of adequate care, are contributing to the expansion of the ophthalmic product industry in India.
It is anticipated that the ophthalmic devices market in India will reach a revenue of INR 0.54 bn by 2025. The market is expected to achieve a compound annual growth rate (CAGR 2024-2029) of 7.91%, resulting in a market size of INR0.79bn by 2029.
With the increasing demand for eye care products, and increasing eye health consciousness, Medibyte is the leading Ophthalmic Eye Drops PCD Franchise, that provides high-standard, quality-approved ophthalmic eye drops and related business solutions.
Table of Contents
ToggleMedibyte stands out among leading eye care pharmaceutical companies that offer a broad selection of eye medications at reasonable prices. We offer top-notch PCD franchise service to anyone with entrepreneurial ambitions. Our focus on meeting the healthcare requirements of the public ensures we deliver the utmost satisfaction to our customers. As our range of eye drops has expanded, we have grown into major suppliers of eye care products in India.
Medibyte is a reputable brand for eye treatments in India, with an extensive selection of ophthalmic drops to treat various eye conditions. Every product manufactured in Eyeris Vision Care has gone through a quality check such as QA/QC departments and has also been clinically proven to give you instant results with quality and purity. We are serving the whole nation with quality formulations including solutions, suspensions, and gels, each with its properties and indications. Covering the Best Ophthalmic Eye Drops for PCD Franchises.
Medibyte has a wide array of product ranges manufactured under the guidelines of WHO-FMP. Here is the tabular presentation of the product range we supplied in pan India.
Medibyte highlights the Ophthalmic Eye Drops PCD Franchise product list below.
Product | Packing | MRP per Box | Rate List Composition |
---|---|---|---|
Azcat-F (Nasal Spray) | 7 ml | 390 | Azelastine Hydrochloride 140 mcg & Fluticasone Propionate 50 mcg (Nasal Spray) |
Cotbet G | 5 ml | 60 | Gentamicin 0.3% + Beclomethasone 0.025% + Clotrimazole 1% + Lignocaine 2% |
Cotbet G | 5 ml | 89 | Gentamicin 0.3% + Beclomethasone 0.025% + Clotrimazole 1% + Lignocaine 2% |
Cxm (0.5%) | 10 ml | 109 | Sodium Carboxy Methyl Cellulose 0.5 %w/v + stabilized oxychloro complex 0.005% w/v |
Cxm (0.5%) | 10 ml | 80 | Sodium Carboxy Methyl Cellulose 0.5 %w/v + stabilized oxychloro complex 0.005% w/v |
Cxm 1% | 10 ml | 159 | Sodium Carboxy Methyl Cellulose 1.0 %w/v + stabilized oxychloro complex 0.005% w/v |
Cxm 1% | 10 ml | 140 | Sodium Carboxy Methyl Cellulose 1.0 %w/v + stabilized oxychloro complex 0.005% w/v |
Finoptis | 5 ml | 98 | Moxifloxacin 0.5% (Eye Drops) |
Finoptis | 5 ml | 70 | Moxifloxacin 0.5% (Eye Drops) |
Finoptis (Ointment) | 5 gm | 70 | Moxifloxacin 0.5 % w/w (Ointment) |
Finoptis (Ointment) | 5 gm | 110 | Moxifloxacin 0.5 % w/w (Ointment) |
Finoptis-B | 5 ml | 140 | Moxifloxacin 0.5 % + Bromfenac 0.09% w/v (Eye Drops) |
Finoptis-D | 5 ml | 110 | Moxifloxacin HCl 0.5% + Dexamthasone 0.1% Eye Drops |
Finoptis-DF | Unit Pack | 150 | Moxifloxacin HCl 0.5% + Difluprednate 0.05% Eye Drops |
Finoptis-K | 5 ml | 80 | Moxifloxacin 0.5% + Ketorolac 0.5% |
Finoptis-K | 5 ml | 99 | Moxifloxacin 0.5% + Ketorolac 0.5% |
Finoptis-LP | Unit Pack | 160 | Moxifloxacin HCl 0.5% + Loteprednol 0.5% Eye Drops |
Finoptis-P | 5 ml | 110 | Moxifloxacin 0.5 % + Prednisolone 0.1% w/v (Eye Drops) |
Fuzrin (Nasal Spray) | 10 ml | 350 | Fluticasone Propionate Nasal Spray 50 mcg IP/BP |
Gatkiv | 5 ml | 45 | Gatifloxacin Othalmic Solution 0.3% Eye Drops |
There is a significant rise in the prevalence of eye disorders such as dry eye syndrome, conjunctivitis, glaucoma, and age-related macular degeneration.
Various elements, such as the rising incidence of eye illnesses, more time spent looking at screens, growing awareness about eye health, and the importance of regular eye check-ups lead to increased use of ophthalmic products.
Additionally, improved access to healthcare facilities and ophthalmologists in urban and rural areas supports this demand.
The India Ophthalmic Pharmaceutical sector is growing at a rapid phase and it is expected to grow. These elements and factors contribute to the Ophthalmic Eye Drops PCD Franchise in India.
Hence, the future of ophthalmic PCD in India looks promising, driven by increasing consumer awareness and the relentless pursuit of excellence in eye care.
There are many benefits to investing in a franchise for ophthalmic eye drop products. There is an increasing need for eye care solutions, making this industry a profitable market.
Owning a PCD franchise comes with the advantage of having a well-known brand, which lowers the risks of launching a new business. You receive access to a clearly defined range of products, marketing assistance, and a distribution channel network.
Furthermore, the growing number of eye problems among people guarantees a consistent need for high-quality eye-care items.
Opting for a franchise in ophthalmic eye drops PCD is a wise decision for individuals looking to capitalize on lucrative prospects in the growing healthcare industry.
Medibyte is the Top pharmaceutical company in India, having the widest range of product portfolio for the PCD Pharma Franchise at the PAN India level. We are an ISO-certified pharmaceutical company.
We ensure the highest quality standards and on-time delivery service at the PAN India level. Medibyte stands as the most reliable and rapidly expanding PCD Pharma Franchise Company in India. Our customer-centric approach has earned us the trust of numerous customers and clients.
As a monopoly-based Ophthalmic Eye Drops PCD Franchise, we offer the chance for you to establish your business in your preferred region. There are several key benefits of investing in the best eye drops, Ophthalmic PCD franchise company – Medibyte:
Launching an ophthalmic PCD franchise with Medibyte presents a bright prospect in the thriving healthcare industry. Here is a detailed outline to help you begin:
Partnering with Medibyte allows you to take advantage of their top-notch products and strong support system, positioning you for success in the Ophthalmic Eye Drops PCD Franchise.
Contact Details
Name:- Medibyte
Mobile No:- +91 9816857058
Address:- Plot No 158, Industrial Area Phase 1, Panchkula, Haryana 134113
Mobile No:- +91 9816857058
Email:- query@drkumarspharma.com